Literature DB >> 27655114

Treatment of Men for "Low Testosterone": A Systematic Review.

Samantha Huo1, Anthony R Scialli2,3, Sean McGarvey2, Elizabeth Hill2, Buğra Tügertimur4, Alycia Hogenmiller2, Alessandra I Hirsch5, Adriane Fugh-Berman2.   

Abstract

Testosterone products are recommended by some prescribers in response to a diagnosis or presumption of "low testosterone" (low-T) for cardiovascular health, sexual function, muscle weakness or wasting, mood and behavior, and cognition. We performed a systematic review of 156 eligible randomized controlled trials in which testosterone was compared to placebo for one or more of these conditions. We included studies in bibliographic databases between January 1, 1950 and April 9, 2016, and excluded studies involving bodybuilding, contraceptive effectiveness, or treatment of any condition in women or children. Studies with multiple relevant endpoints were included in all relevant tables. Testosterone supplementation did not show consistent benefit for cardiovascular risk, sexual function, mood and behavior, or cognition. Studies that examined clinical cardiovascular endpoints have not favored testosterone therapy over placebo. Testosterone is ineffective in treating erectile dysfunction and controlled trials did not show a consistent effect on libido. Testosterone supplementation consistently increased muscle strength but did not have beneficial effects on physical function. Most studies on mood-related endpoints found no beneficial effect of testosterone treatment on personality, psychological well-being, or mood. The prescription of testosterone supplementation for low-T for cardiovascular health, sexual function, physical function, mood, or cognitive function is without support from randomized clinical trials.

Entities:  

Year:  2016        PMID: 27655114      PMCID: PMC5031462          DOI: 10.1371/journal.pone.0162480

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  168 in total

1.  Effect of testosterone treatment on bone mineral density in men over 65 years of age.

Authors:  P J Snyder; H Peachey; P Hannoush; J A Berlin; L Loh; J H Holmes; A Dlewati; J Staley; J Santanna; S C Kapoor; M F Attie; J G Haddad; B L Strom
Journal:  J Clin Endocrinol Metab       Date:  1999-06       Impact factor: 5.958

2.  DHEA in elderly women and DHEA or testosterone in elderly men.

Authors:  K Sreekumaran Nair; Robert A Rizza; Peter O'Brien; Ketan Dhatariya; Kevin R Short; Ajay Nehra; Janet L Vittone; George G Klee; Ananda Basu; Rita Basu; Claudio Cobelli; Gianna Toffolo; Chiara Dalla Man; Donald J Tindall; L Joseph Melton; Glenn E Smith; Sundeep Khosla; Michael D Jensen
Journal:  N Engl J Med       Date:  2006-10-19       Impact factor: 91.245

3.  Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation.

Authors:  Thomas G Travison; Shehzad Basaria; Thomas W Storer; Alan M Jette; Renee Miciek; Wildon R Farwell; Karen Choong; Kishore Lakshman; Norman A Mazer; Andrea D Coviello; Philip E Knapp; Jagadish Ulloor; Anqi Zhang; Brad Brooks; Ahn-Hoa Nguyen; Richard Eder; Nathan LeBrasseur; Ayan Elmi; Erica Appleman; Leife Hede-Brierley; Geeta Bhasin; Ashmeet Bhatia; Antonio Lazzari; Samuel Davis; Pengsheng Ni; Lauren Collins; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-06-22       Impact factor: 6.053

4.  Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

Authors:  Stephanie T Page; John K Amory; F Dubois Bowman; Bradley D Anawalt; Alvin M Matsumoto; William J Bremner; J Lisa Tenover
Journal:  J Clin Endocrinol Metab       Date:  2004-11-30       Impact factor: 5.958

5.  The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.

Authors:  Chris J Malkin; Peter J Pugh; Richard D Jones; Dheeraj Kapoor; Kevin S Channer; T Hugh Jones
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

6.  Effect of long-term oral testosterone undecanoate treatment on prostate volume and serum prostate-specific antigen concentration in eugonadal middle-aged men.

Authors:  S Holmäng; P Mårin; G Lindstedt; H Hedelin
Journal:  Prostate       Date:  1993       Impact factor: 4.104

7.  AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function.

Authors:  C Steidle; S Schwartz; K Jacoby; T Sebree; T Smith; R Bachand
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

8.  Testosterone therapy increases sexual desire in ageing men with low-normal testosterone levels and symptoms of androgen deficiency.

Authors:  C A Allan; E A Forbes; B J G Strauss; R I McLachlan
Journal:  Int J Impot Res       Date:  2008-06-05       Impact factor: 2.896

9.  Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction.

Authors:  Antonio Aversa; Andrea M Isidori; Giovanni Spera; Andrea Lenzi; Andrea Fabbri
Journal:  Clin Endocrinol (Oxf)       Date:  2003-05       Impact factor: 3.478

10.  Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).

Authors:  T Hugh Jones; Stefan Arver; Hermann M Behre; Jacques Buvat; Eric Meuleman; Ignacio Moncada; Antonio Martin Morales; Maurizio Volterrani; Ann Yellowlees; Julian D Howell; Kevin S Channer
Journal:  Diabetes Care       Date:  2011-03-08       Impact factor: 19.112

View more
  20 in total

Review 1.  Sex as a Biological Variable in Atherosclerosis.

Authors:  Joshua J Man; Joshua A Beckman; Iris Z Jaffe
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

Review 2.  The Rise and Fall of Estrogen Therapy: Is Testosterone for "Manopause" Next?

Authors:  Briana T Costello; Keri Sprung; Stephanie A Coulter
Journal:  Tex Heart Inst J       Date:  2017-10-01

Review 3.  Management of Dyslipidemia in Endocrine Diseases.

Authors:  Lisa R Tannock
Journal:  Endocrinol Metab Clin North Am       Date:  2022-07-06       Impact factor: 4.748

4.  Cognitive response to testosterone replacement added to intensive lifestyle intervention in older men with obesity and hypogonadism: prespecified secondary analyses of a randomized clinical trial.

Authors:  Giulia Gregori; Alessandra Celli; Yoann Barnouin; Arjun Paudyal; Reina Armamento-Villareal; Nicola Napoli; Clifford Qualls; Dennis T Villareal
Journal:  Am J Clin Nutr       Date:  2021-11-08       Impact factor: 8.472

5.  Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis.

Authors:  Jemma Hudson; Moira Cruickshank; Richard Quinton; Lorna Aucott; Magaly Aceves-Martins; Katie Gillies; Shalender Bhasin; Peter J Snyder; Susan S Ellenberg; Mathis Grossmann; Thomas G Travison; Emily J Gianatti; Yvonne T van der Schouw; Marielle H Emmelot-Vonk; Erik J Giltay; Geoff Hackett; Sudarshan Ramachandran; Johan Svartberg; Kerry L Hildreth; Kristina Groti Antonic; Gerald B Brock; J Lisa Tenover; Hui Meng Tan; Christopher Ho Chee Kong; Wei Shen Tan; Leonard S Marks; Richard J Ross; Robert S Schwartz; Paul Manson; Stephen Roberts; Marianne Skovsager Andersen; Line Velling Magnussen; Rodolfo Hernández; Nick Oliver; Frederick Wu; Waljit S Dhillo; Siladitya Bhattacharya; Miriam Brazzelli; Channa N Jayasena
Journal:  Lancet Healthy Longev       Date:  2022-06

Review 6.  The role of the androgen receptor in the pathogenesis of obesity and its utility as a target for obesity treatments.

Authors:  Varun S Venkatesh; Mathis Grossmann; Jeffrey D Zajac; Rachel A Davey
Journal:  Obes Rev       Date:  2022-01-27       Impact factor: 10.867

7.  Emotions and Steroid Secretion in Aging Men: A Multi-Study Report.

Authors:  Andreas Walther; Patricia Waldvogel; Emilou Noser; Jessica Ruppen; Ulrike Ehlert
Journal:  Front Psychol       Date:  2017-09-29

8.  Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism: A Real-Life Observational Registry Study Setting Comparing Treated and Untreated (Control) Groups.

Authors:  Abdulmaged M Traish; Ahmad Haider; Karim Sultan Haider; Gheorghe Doros; Farid Saad
Journal:  J Cardiovasc Pharmacol Ther       Date:  2017-02-09       Impact factor: 2.457

Review 9.  Testosterone Replacement Therapy: Long-Term Safety and Efficacy.

Authors:  Giovanni Corona; Alessandra Sforza; Mario Maggi
Journal:  World J Mens Health       Date:  2017-04-30       Impact factor: 5.400

10.  Letter to the Editor regarding 'Treatment of Men for "Low Testosterone": A Systematic Review' by Huo et al.; Testosterone Replacement Therapy: Toward to the Robust Evidence and Facts.

Authors:  Jae Hung Jung; Sang-Kuk Yang
Journal:  World J Mens Health       Date:  2016-12-22       Impact factor: 5.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.